Informed Prescribing Support
Help reduce the trial-and-error approach by providing genetic insights into how your liver enzymes may metabolize specific prescription therapies.
One non-invasive at-home cheek swab provides genetic insights to help you and your prescribing healthcare provider evaluate how your body may metabolize and respond to specific medications.
Stop the medication guesswork. Start personalizing your care with clinical genetic insights.
PGx Medication Genetics Kit
You save $100
Secure & confidential clinical processing
Simple, at-home collection with licensed provider review
A CLIA-certified laboratory analyzes your key drug-metabolizing enzymes (CYP450 pathways).
A clinical look inside your genetic pathways to help your provider tailor medication strategies.
Every individual processes medications differently. Optimize PGx translates key genetic variants into clear, actionable insights your prescribing doctor can use to make more informed treatment decisions.
Help your doctor anticipate how your liver enzymes may metabolize specific therapies before starting a new prescription.
Identify genetic variations linked to standard, intermediate, poor, or ultra-rapid metabolism to help minimize unexpected adverse responses.
Clear, clinically structured reports designed specifically to be shared with and interpreted by your licensed prescribing healthcare provider.
Help reduce the trial-and-error approach by providing genetic insights into how your liver enzymes may metabolize specific prescription therapies.
Evaluate core pharmacokinetic pathways (including the CYP450 enzyme family) that directly influence drug clearance, activation, and breakdown.
Receive a clear, clinically structured report tailored for you to review directly with your prescribing physician or clinical pharmacist.
Comprehensive pharmacogenomic profiling across essential therapeutic areas to inform discussions with your prescribing healthcare provider.
Explore genetic variations influencing the breakdown and transport of common antidepressants, mood stabilizers, and anxiolytics.
Understand genetic factors associated with blood thinner response (including antiplatelet pathways), statin sensitivity, and blood pressure management.
Identify liver enzyme variations that may affect how your body metabolizes pain relief therapies and anti-inflammatory medications.
Profile essential metabolic pathways (such as CYP2D6, CYP2C19, CYP2C9, and CYP3A4) to evaluate standard, intermediate, poor, or rapid metabolizer status.
Examine how your genetic profile interacts with common proton pump inhibitors (PPIs) and stomach acid control medications.
Evaluate genetic variations that help healthcare providers assess biological response to select immunosuppressants and targeted therapies.
Explore genetic variations influencing the breakdown and transport of common antidepressants, mood stabilizers, and anxiolytics.
Optimize PGx — Medication Genetics Kit. One non-invasive cheek swab and a clinical report reviewed by a qualified healthcare professional.
Secure & confidential clinical processing